Thrombolytic therapy and equivalence trials.
White
H D
HD
D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000494:pharmacology*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000494:pharmacology; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator; C067551:saruplase